Elicio Therapeutics, Inc. (ELTX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -11.64M | -6.8M | -11.09M | -8.95M | -10.12M | -8.74M | -7.27M | -8.93M | -12.12M | -9.9M | -5.18M | -9.54M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -15.08% | 22.27% | -52.41% | -0.25% | 16.52% | 11.64% | -40.32% | 6.37% | -48.94% | -36.01% | 3.75% | - |
| Net Income | -11.82M | -7.72M | -10.08M | -10.56M | -11.21M | -14M | -18.84M | -7.23M | -11.83M | -8.95M | -10.66M | -7.56M |
| Depreciation & Amortization | 289K | 286K | 283K | 281K | 278K | 305K | 290K | 293K | 290K | 286K | 273K | 0 |
| Stock-Based Compensation | 0 | 772K | 698K | 710K | 517K | 464K | 327K | 350K | 324K | 337K | 339K | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 16K | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.92M | -1.58M | 2.19M | 971K | 649K | 806K | 9.17M | -3.62M | 1.85M | 59K | 98K | -3.36M |
| Working Capital Changes | -2.03M | 1.44M | -4.18M | -351K | -354K | 3.69M | 1.76M | 1.27M | -2.76M | -1.63M | 4.77M | 1.39M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -460K | 351K | -3.54M | -172K | 3M | -946K | 929K | -50K | -3.26M | -40K | 142K | 1.75M |
| Cash from Investing | 0 | -16K | 0 | 0 | 0 | -45K | 0 | -42K | 3K | 0 | -45K | 10.01M |
| Capital Expenditures | 0 | -16K | 0 | 0 | 0 | -45K | -42K | -42K | 0 | 0 | -45K | -21K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34K |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 42K | 0 | 3K | 0 | 0 | 10M |
| Cash from Financing | 8.03M | 4.86M | 9.57M | 11.93M | 10.33M | 227K | 30.75M | 316K | 11.02M | 7M | 59K | 34.82M |
| Debt Issued (Net) | 0 | 0 | 9.87M | 0 | 0 | 0 | 19.73M | 0 | 0 | 10M | 0 | 3.27M |
| Equity Issued (Net) | 8.03M | 4.86M | -294K | 2.02M | 10.33M | 222K | 48K | 303K | 5.06M | -3M | 10.06M | -83K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -150K | 150K | -150K |
| Other Financing | 0 | 0 | 0 | 9.92M | 0 | 5K | 10.98M | 13K | 5.96M | 3K | -10M | 31.64M |
| Net Change in Cash | -3.62M | -2.05M | -1.48M | 3.06M | 240K | -8.54M | 23.52M | -8.7M | -1.09M | -2.9M | -5.17M | -6.92M |
| Free Cash Flow | -11.64M | -6.81M | -11.09M | -8.95M | -10.12M | -8.79M | -7.27M | -8.97M | -12.12M | -9.9M | -5.23M | -9.56M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -15.08% | 22.48% | -52.41% | 0.22% | 16.52% | 11.19% | -39.11% | 6.13% | -48.63% | -34.26% | 2.92% | - |
| FCF per Share | -0.64 | -0.44 | -0.66 | -0.56 | -0.78 | -0.72 | -0.54 | -0.79 | -1.18 | -1.03 | -1.28 | -3.08 |
| FCF Conversion (FCF/Net Income) | 0.98x | 0.88x | 1.10x | 0.85x | 0.90x | 0.62x | 0.39x | 1.24x | 1.02x | 1.11x | 0.49x | 1.26x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |